Peptides in oncology, 2.. Somatostatin analogues and Bombesin antagonists : with 14 tables
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISBN
-
9783540566694
3540566694
9780387566696
0387566694
- Extent
-
X, 136 S.
- Language
-
Englisch
- Notes
-
graph. Darst.
- Bibliographic citation
-
Peptides in oncology
Recent results in cancer research ; 129
- Event
-
Veröffentlichung
- (where)
-
Berlin, Heidelberg, New York, Barcelona, Hong Kong, London, Milan, Paris, Singapore, Tokyo
- (who)
-
Springer
- (when)
-
1993
- Table of contents
- Rights
-
Bei diesem Objekt liegt nur das Inhaltsverzeichnis digital vor. Der Zugriff darauf ist unbeschränkt möglich.
- Last update
-
11.06.2025, 1:56 PM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Springer
Time of origin
- 1993
Other Objects (12)
Peptides in oncology, 3.. Somatostatin and LH-RH analogues : with 14 tables
Peptides in oncology, 1.. LH-RH agonists and antagonists : with 11 tables
Somatostatin analogues labeled with copper radioisotopes: current status
Somatostatin receptor subtype 2-mediated uptake of radiolabelled somatostatin analogues in the human kidney
Combined treatment of somatostatin analogues with pegvisomant in acromegaly
Somatostatin receptor antagonists as a theranostic option in iodine-refractory thyroid carcinoma
Interpreting biochemical control response rates with first-generation somatostatin analogues in acromegaly
Initiation of Somatostatin analogues for neuroendocrine tumor patients: a cost-effectiveness analysis
Effective management of recurrent Doege–Potter syndrome with somatostatin‐analogues: a case report
Long-term remission of acromegaly after somatostatin analogues withdrawal: a single-centre experience
A Multicenter Experience with Long-Acting Somatostatin Analogues in Patients with Congenital Hyperinsulinism
Synthese von Somatostatin und [Tyr11]-Somatostatin [Tyr-Somatostatin]
Peptides in oncology, 3.. Somatostatin and LH-RH analogues : with 14 tables
Peptides in oncology, 1.. LH-RH agonists and antagonists : with 11 tables
Somatostatin analogues labeled with copper radioisotopes: current status
Somatostatin receptor subtype 2-mediated uptake of radiolabelled somatostatin analogues in the human kidney
Combined treatment of somatostatin analogues with pegvisomant in acromegaly
Somatostatin receptor antagonists as a theranostic option in iodine-refractory thyroid carcinoma
Interpreting biochemical control response rates with first-generation somatostatin analogues in acromegaly
Initiation of Somatostatin analogues for neuroendocrine tumor patients: a cost-effectiveness analysis
Effective management of recurrent Doege–Potter syndrome with somatostatin‐analogues: a case report
Long-term remission of acromegaly after somatostatin analogues withdrawal: a single-centre experience
A Multicenter Experience with Long-Acting Somatostatin Analogues in Patients with Congenital Hyperinsulinism
Synthese von Somatostatin und [Tyr11]-Somatostatin [Tyr-Somatostatin]
Peptides in oncology, 3.. Somatostatin and LH-RH analogues : with 14 tables
Peptides in oncology, 1.. LH-RH agonists and antagonists : with 11 tables
Somatostatin analogues labeled with copper radioisotopes: current status
Somatostatin receptor subtype 2-mediated uptake of radiolabelled somatostatin analogues in the human kidney
Combined treatment of somatostatin analogues with pegvisomant in acromegaly
Somatostatin receptor antagonists as a theranostic option in iodine-refractory thyroid carcinoma
Interpreting biochemical control response rates with first-generation somatostatin analogues in acromegaly
Initiation of Somatostatin analogues for neuroendocrine tumor patients: a cost-effectiveness analysis
Effective management of recurrent Doege–Potter syndrome with somatostatin‐analogues: a case report
Long-term remission of acromegaly after somatostatin analogues withdrawal: a single-centre experience
A Multicenter Experience with Long-Acting Somatostatin Analogues in Patients with Congenital Hyperinsulinism